Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 672

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

Open access
Migliaccio, A.·2000·The EMBO Journal
DOI 10.1093/emboj/19.20.5406
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emboj/19.20.5406

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 59

  1. Abbondanza C et al. (1998) Interaction of vault particles with estrogen receptor in the MCF‐7 breast cancer cell. J Cell Biol, 141, 1301–1310. · DOI
  2. Abreu‐Martin MT, Chari A, Palladino AA, Craft NA and Sawyers CL (1999) Mitogen‐activated protein kinase kinase kinase 1 activates androgen receptor‐dependent transcription and apoptosis in prostate cancer. Mol Cell Biol, 19, 5143–5154. · DOI · Paper page
  3. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR (1995) PD098059 is a specific inhibitor of mitogen‐activated protein kinase kinase in vitro and in vivo. J Biol Chem, 270, 27489–27494. · DOI · Paper page
  4. Arnold SF, Obourn JD, Jaffe H and Notides AC (1995) Phosphoryl ation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol Endocrinol, 9, 24–33.
  5. Auricchio F, Di Domenico M, Migliaccio A, Castoria G and Bilancio A (1995) The role of estradiol receptor in the proliferative activity of vanadate in MCF‐7 cells. Cell Growth Differ, 6, 105–113.
  6. Barone MV and Courtneidge SA (1995) Myc but not Fos rescue of PDGF signalling block caused by kinase‐inactive Src. Nature, 378, 509–512. · DOI · Paper page
  7. Beato M, Herrlich P and Schutz G (1995) Steroid‐hormone receptors: many actors in search of a plot. Cell, 83, 851–857. · DOI · Paper page
  8. Carter HB and Coffey DS (1990) The prostate: an increasing medical problem. Prostate, 16, 39–48. · DOI · Paper page
  9. Castagnetta LA, Miceli MD, Sorci CMG, Pfeffer U, Farruggio R, Oliveri G, Calabrò M and Carruba G (1995) Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology, 136, 2309–2319. · doi:10.1210/endo.136.5.7536668
  10. Castoria G, Migliaccio A, Green S, Di Domenico M, Chambon P and Auricchio F (1993) Properties of a purified estradiol‐dependent calf uterus tyrosine kinase. Biochemistry, 32, 1740–1750. · doi:10.1021/bi00058a007
  11. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A and Auricchio F (1999) Non‐transcriptional action of estrogen and progestin triggers DNA synthesis. EMBO J, 18, 2500–2510. · DOI · Paper page
  12. Chang CS, Kokontis J and Liao ST (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science, 240, 324–326. · DOI · Paper page
  13. Chen Z, Yuhanna IS, Galcheva‐Garcova Z, Karas RH, Mendelsohn ME and Shaul PW (1999) Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest, 103, 401–406. · DOI · Paper page
  14. Cowley S, Paterson H, Kemp P and Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell, 77, 841–852. · DOI · Paper page
  15. Di Domenico M, Castoria G, Bilancio A, Migliaccio A and Auricchio F (1996) Estradiol activation of human colon carcinoma‐derived Caco‐2 cell growth. Cancer Res, 56, 4516–4521.
  16. Dickson RB and Lippman ME (1987) Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev, 8, 29–43. · DOI · Paper page
  17. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S and Kawashima H (1997) Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun, 235, 99–102. · DOI · Paper page
  18. Enmark E, Pelto‐Huikko M, Grandien K, Lagerkrantz J, Fried G, Nordenskjold M and Gustafsson JA (1997) Human estrogen receptor β—gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab, 82, 4258–4265.
  19. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science, 240, 889–895. · DOI · Paper page
  20. Gorski J (1997) Do we need new paradigms? Endocr News, 22, 4–12.
  21. Hanke JH, Gardner JP, Dow RL, Changeliau PS, Brisselte WH, Weringer EJ, Pollok BA and Connelly PA (1996) Discovery of a novel, potent and Src family‐selective tyrosine kinase inhibitor. Study of Lck‐ and FynT‐dependent T cell activation. J Biol Chem, 271, 695–701. · DOI · Paper page
  22. Horoszewics JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res, 43, 1809–1818.
  23. Hubbard SR, Mohammadi M and Schlessinger J (1998) Auto regulatory mechanisms in protein‐tyrosine kinases. J Biol Chem, 273, 11987–11990. · DOI · Paper page
  24. Kaelin WG, Pallas DC, De Caprio JA, Kaye FJ and Livingston DM (1991) Identification of cellular proteins that can interact with the T/E1A‐binding region of the retinoblastoma product. Cell, 64, 521–532. · DOI · Paper page
  25. Kuiper GGJM and Gustafsson JA (1997) The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens. FEBS Lett, 410, 87–90. · DOI · Paper page
  26. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S and Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138, 863–870. · DOI · Paper page
  27. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B and Gustafsson JA (1998) Interaction of estrogenic chemicals and phytestrogens with estrogen receptor β. Endocrinology, 139, 4252–4263. · DOI · Paper page
  28. Lee HW and Eghbali‐Webb M, (1998) Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor‐ and mitogen‐activated protein kinase‐dependent pathway. J Mol Cell Cardiol, 30, 1359–1368. · DOI
  29. Loose‐Mitchell DS, Chiappetta C and Stancel GM (1988) Estrogen regulation of c‐fos messenger ribonucleic acid. Mol Endocrinol, 2, 946–951. · DOI · Paper page
  30. Matsuda M, Mayer BJ, Fukui Y and Hanafusa H (1990) Binding of transforming protein, P47gag‐crk to a broad range of phosphotyrosine‐containing proteins. Science, 248, 1537–1539. · DOI · Paper page
  31. McEwen BS and Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev, 20, 279–307.
  32. McKenna NJ, Lanz RB and O'Malley BW (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev, 20, 321–344.
  33. Migliaccio A, Pagano M and Auricchio F (1993) Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF‐7. Oncogene, 8, 2183–2191.
  34. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F (1996) Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol–receptor complex in MCF‐7 cells. EMBO J, 15, 1292–1300. · DOI · Paper page
  35. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M and Auricchio F (1998) Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen. EMBO J, 17, 2008–2018. · DOI · Paper page
  36. Parker MG and White R (1996) Nuclear receptors spring into action. Nature Struct Biol, 3, 113–115. · DOI
  37. Peterziel H, Mink S, Schonert A, Becker M, Kocler H and Cato ACB (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene, 18, 6322–6329. · DOI · Paper page
  38. Pietras RJ et al. (1995) HER‐2 tyrosine kinase pathway targets estrogen receptor and promotes hormone‐independent growth in human breast cancer cells. Oncogene, 10, 2435–2446.
  39. Power RF, Mani SK, Codina J, Conneely OM and O'Malley BW (1991) Dopaminergic and ligand‐independent activation of steroid hormone receptor. Science, 254, 1636–1639. · DOI · Paper page
  40. Razandi M, Pedram A, Greene GL and Levin ER (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol, 13, 307–319.
  41. Revelli A, Massobrio M and Tesarik J (1998) Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev, 19, 3–17.
  42. Scardino PT, Weaver R and Hudson MA (1992) Early detection of prostate cancer. Hum Pathol, 23, 211–222. · DOI · Paper page
  43. Schlessinger J (2000) New roles for Src kinases in control of cell survival and angiogenesis. Cell, 100, 293–296. · DOI · Paper page
  44. Schuurmans AL, Bolt J, Velscholte J and Mulder E (1991) Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol, 40, 193–197. · DOI
  45. Singer CA, Figueroa‐Masot XA, Batchelor RH and Dorsa DM (1999) The mitogen‐activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci, 19, 2455–2463. · DOI · Paper page
  46. Singh M, Setáló G, Guan X, Warren M and Toran‐Allerand CD (1999) Estrogen‐induced activation of mitogen‐activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci, 19, 1179–1188. · DOI · Paper page
  47. Sonnenschein C, Olea N, Pasanen ME and Soto AM (1989) Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res, 49, 3474–3481.
  48. Superti‐Furga G, Fumagalli S, Koegl M, Courtneidge SA and Draetta G (1993) Csk inhibition of c‐Src activity requires both the SH2 and SH3 domains of Src. EMBO J, 12, 2625–2634. · DOI · Paper page
  49. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P (1989) The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J, 8, 1981–1986. · DOI · Paper page
  50. Veldscholte J et al. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti‐androgens. Biochem Biophys Res Commun, 173, 534–540. · DOI · Paper page
  51. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG and Dorsa DM (1997) Rapid membrane effects of steroids in neuroblastoma cells: effect of estrogen on mitogen activated protein kinase signalling cascade and c‐fos immediate early gene transcription. Endocrinology, 138, 4030–4033. · doi:10.1210/endo.138.9.5489 · Paper page
  52. Wehling M (1997) Specific, nongenomic actions of steroid hormones. Annu Rev Physiol, 59, 365–393. · DOI · Paper page
  53. Weisz A and Bresciani F (1993) Estrogen regulation of proto‐oncogenes coding for nuclear proteins. Crit Rev Oncog, 4, 361–388.
  54. White R, Sjöberg M, Kalkhoven E and Parker GM (1997) Ligand independent activation of oestrogen receptor by mutation of a conserved tyrosine. EMBO J, 16, 1427–1435. · DOI
  55. Wilding G (1992) The importance of steroid hormones in prostate cancer. Cancer Surv, 14, 113–130.
  56. Wilson JD (1980) The pathogenesis of benign prostatic hyperplasia. Am J Med, 68, 745–747. · DOI · Paper page
  57. Xu W, Doshi A, Lei M, Eck MJ and Harrison SC (1999) Crystal structures of c‐Src reveal features of its autoinhibitory mechanism. Mol Cell, 3, 629–638. · DOI · Paper page
  58. Yeh S, Lin H‐K, Kang H‐Y, Thin TH, Lin M‐F and Chang C (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA, 96, 5458–5463. · DOI · Paper page
  59. Zhang Y, Bai W, Allgood VE and Weigel NL (1994) Multiple signalling pathways activate chicken progesterone receptor. Mol Endocrinol, 8, 577–584.

Cited by

See all 672

Metadata

Authors
Migliaccio, A.
Venue
The EMBO Journal
Publisher
Springer Science and Business Media LLC
Published
2000-10-16
Volume
19
Issue
20
Pages
5406-5417
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
DOI
10.1093/emboj/19.20.5406
OpenAlex
W2160084272
Cited by
672
References
1
FWCI
18.37
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. https://app.cochat.ai/papers/10.1093/emboj/19.20.5406
The paper
Migliaccio, A. (2000). Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. The EMBO Journal. https://doi.org/10.1093/emboj/19.20.5406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.